Faculty Opinions recommendation of Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697922.793152993 ◽

2012 ◽

Author(s):

Mitesh Borad

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Stromal Tumor ◽

Efficacy And Safety ◽

Multicenter Phase ◽

Gi Stromal Tumor

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697922.793456605 ◽

2012 ◽

Author(s):

Florence Duffaud

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Stromal Tumor ◽

Efficacy And Safety ◽

Multicenter Phase ◽

Gi Stromal Tumor

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697922.793454535 ◽

2012 ◽

Author(s):

Josep Tabernero ◽

Elena Elez

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Stromal Tumor ◽

Efficacy And Safety ◽

Multicenter Phase ◽

Gi Stromal Tumor

Download Full-text

Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy)

Investigational New Drugs ◽

10.1007/s10637-008-9166-8 ◽

2008 ◽

Vol 27 (2) ◽

pp. 166-172 ◽

Author(s):

G. Schilling ◽

M. Bruweleit ◽

N. Harbeck ◽

C. Thomssen ◽

K. Becker ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Her2 Positive ◽

Multicenter Phase

Download Full-text

Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2009-2272 ◽

2010 ◽

Vol 95 (6) ◽

pp. 2781-2789 ◽

Author(s):

S. Petersenn ◽

J. Schopohl ◽

A. Barkan ◽

P. Mohideen ◽

A. Colao ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Multicenter Phase

Download Full-text

Efficacy and safety of regorafenib in patients with metastatic and/or unresectable gastrointestinal stromal tumor harboring secondary mutation with exon 17: Interim report of a phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e22511 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e22511-e22511 ◽

Author(s):

Chun-Nan Yeh

Keyword(s):

Gastrointestinal Stromal Tumor ◽

Phase Ii ◽

Phase Ii Trial ◽

Stromal Tumor ◽

Secondary Mutation ◽

Efficacy And Safety ◽

Download Full-text

422P The efficacy and safety of irinotecan plus raltitrexed as second-line treatment in advanced colorectal cancer (ACC) patients: A summary analysis of a multicenter, phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.943 ◽

2021 ◽

Vol 32 ◽

pp. S546

Author(s):

X. Qu ◽

Y. Liu ◽

Z. Teng ◽

Y. Zhang ◽

D.Z. Zheng ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

Second Line ◽

Efficacy And Safety ◽

Multicenter Phase

Download Full-text

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)

International Journal of Hematology ◽

10.1007/s12185-018-2401-y ◽

2018 ◽

Vol 107 (5) ◽

pp. 535-540 ◽

Author(s):

Jun Ishikawa ◽

Itaru Matsumura ◽

Tatsuya Kawaguchi ◽

Junya Kuroda ◽

Hirohisa Nakamae ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Molecular Response ◽

Efficacy And Safety ◽

Major Molecular Response ◽

Multicenter Phase

Download Full-text

963MO Naxitamab for the treatment of refractory/relapsed high-risk neuroblastoma (HR NB): Updated efficacy and safety data from the international, multicenter phase II trial 201

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1348 ◽

2021 ◽

Vol 32 ◽

pp. S833

Author(s):

J. Mora ◽

M. Bear ◽

G. Chan ◽

D.A. Morgenstern ◽

K. Nysom ◽

...

Keyword(s):

High Risk ◽

Phase Ii ◽

Phase Ii Trial ◽

Safety Data ◽

Efficacy And Safety ◽

Multicenter Phase ◽

International Multicenter

Download Full-text

Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (AGO GYN 5)

Gynecologic Oncology ◽

10.1016/j.ygyno.2014.03.576 ◽

2014 ◽

Vol 133 (3) ◽

pp. 427-432 ◽

Author(s):

Günter Emons ◽

Grigor Gorchev ◽

Jalid Sehouli ◽

Pauline Wimberger ◽

Anne Stähle ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Study Group ◽

Lhrh Agonist ◽

Efficacy And Safety ◽

Multicenter Phase ◽

Platinum Refractory

Download Full-text

Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial

The Journal of Dermatology ◽

10.1111/1346-8138.15836 ◽

2021 ◽

Author(s):

Keita Tsutsui ◽

Katsuko Kikuchi ◽

Keiko Nozawa ◽

Atsuo Takashima ◽

Kenichiro Tsuchiyama ◽

...

Keyword(s):

Benzoyl Peroxide ◽

Phase Ii ◽

Phase Ii Trial ◽

Efficacy And Safety ◽

Multicenter Phase

Download Full-text